Additionally, we evaluated the therapeutic potential of two small molecules; eupatilin, a plant-derived flavonoid previously shown to improve cilia dysfunction in CEP290-associated ciliopathy models [24, 25], and fasudil hydrochloride, a selective ROCK2 inhibitor reported to restore cilia formation in various ciliopathy models [26]. The gene discussed is ROCK2; the disease is ciliopathy.